Dr. Mark Howard Duncan, MD

Dr. Duncan practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Duncan's NPI, 1871791913, was assigned on July 10, 2007. Dr. Duncan graduated from Rush Medical College in 2006. Dr. Duncan holds Washington license MD60101453.

Dr. Duncan's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Duncan's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Duncan to 1 more hospital, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Duncan practices, 4 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Duncan's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dmand AI has Dr. Duncan's licenses on file in 2 states: Washington and Illinois.

Dmand AI lists ADHD, anxiety, bipolar disorder, depression, drug use disorders, insomnia, schizophrenia and tobacco use among the conditions Dr. Duncan treats.

CMS data shows 114 Medicare services from Dr. Duncan across 2 procedure codes in 2024, for 26 Medicare patients. Medicare paid $5,006 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw Dr. Duncan in 2024. The largest group is under 65, with 11 patients. 75% of them have mood disorders, and 73% have anxiety. 42% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Duncan's median patient age at 48, with 57% women.

In 2024, Dr. Duncan wrote 630 Medicare Part D claims for 34 patients. 96% of them were for generic drugs. CMS names the drug for 501 of them, across 24 drugs with 11 or more claims each, at $19,375 in total drug cost. In 2023, CMS named 454 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Duncan for performance year 2024, reported through an alternative payment model (APM). Dr. Duncan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Duncan as offering telehealth.

Dmand AI links 11 papers to Dr. Duncan, published from 2014 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Primary Health Care, Mental Disorders and Alcoholism. Dr. Duncan has published most often in Ann Intern Med. Dr. Duncan's most frequent co-authors are Joseph Owen Merrill, Eric R. Arzubi, MD and Amritha Subray Bhat, MD.

CMS Open Payments shows 5 general payments to Dr. Duncan from 5 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 83% of the total. Eli Lilly and Company paid the most, $467.

Dr. Duncan graduated from Rush Medical College in 2006.

Dr. Duncan is in network with 8 carriers, including United Healthcare, Aetna and Humana. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.